News

Year Follow-Up from a Prospective, Multicenter Study of Percutaneous 60-Day Peripheral Nerve Stimulation for Chronic Low Back ...
Millions of people around the world suffer from chronic low back pain, a condition that often lingers for years and ...
In a preclinical study led by McGill University researchers, two drugs targeting "zombie cells" have been shown to treat the ...
Research suggests that better understanding the psychological and neurological components of chronic pain may lead to better ...
Higher exercise adherence led to greater improvements in pain and functional limitations among adults with chronic low back pain.
Two oral drugs — o-Vanillin and RG-7112 — cleared zombie cells, reduced back pain and reversed spinal disc damage in mice.
For acute lower back pain, non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, were among the few treatments ...
Anthem Blue Cross and Blue Shield established favorable coverage for Mainstay Medical Holdings’ Reactiv8 restorative neurostimulation for intractable chronic low back pain. Coverage went into effect ...
In a preclinical study, two drugs targeting 'zombie cells' have been shown to treat the underlying cause of chronic low back pain. The condition affects millions of people worldwide. Current ...
Part B covers up to 12 acupuncture treatments in a 90-day period for chronic lower back pain. Some Advantage plans may also cover acupuncture for other chronic pain conditions, such as chronic ...
Mindfulness and cognitive behavioral therapy (CBT) both improve symptoms of chronic low back pain. | Neuroscience ...
two drugs targeting “zombie cells” have been shown to treat the underlying cause of chronic low back pain. The condition affects millions of people worldwide. Current treatments manage ...